Cargando…
1612P Immunogenicity of two doses of inactive COVID-19 vaccine and third booster dose mRNA vaccine in patients with cancer receiving active systemic therapy
| Autores principales: | , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
European Society for Medical Oncology. Published by Elsevier Ltd.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9472463/ http://dx.doi.org/10.1016/j.annonc.2022.07.1705 |
| _version_ | 1784789309407100928 |
|---|---|
| author | Guven, D.C.C. Gulbahce Incesu, F.G. Yildirim, H.C. Erul, E. Chalabiyev, E. Aktas, B.Y. Yuce, D. Arik, Z. Kilickap, S. Aksoy, S. Erman, M. Hayran, K.M. Unal, S. Alp, A. Dizdar, O. |
| author_facet | Guven, D.C.C. Gulbahce Incesu, F.G. Yildirim, H.C. Erul, E. Chalabiyev, E. Aktas, B.Y. Yuce, D. Arik, Z. Kilickap, S. Aksoy, S. Erman, M. Hayran, K.M. Unal, S. Alp, A. Dizdar, O. |
| author_sort | Guven, D.C.C. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9472463 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | European Society for Medical Oncology. Published by Elsevier Ltd. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-94724632022-09-14 1612P Immunogenicity of two doses of inactive COVID-19 vaccine and third booster dose mRNA vaccine in patients with cancer receiving active systemic therapy Guven, D.C.C. Gulbahce Incesu, F.G. Yildirim, H.C. Erul, E. Chalabiyev, E. Aktas, B.Y. Yuce, D. Arik, Z. Kilickap, S. Aksoy, S. Erman, M. Hayran, K.M. Unal, S. Alp, A. Dizdar, O. Ann Oncol Article European Society for Medical Oncology. Published by Elsevier Ltd. 2022-09 2022-09-13 /pmc/articles/PMC9472463/ http://dx.doi.org/10.1016/j.annonc.2022.07.1705 Text en Copyright © 2022 European Society for Medical Oncology. Published by Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Article Guven, D.C.C. Gulbahce Incesu, F.G. Yildirim, H.C. Erul, E. Chalabiyev, E. Aktas, B.Y. Yuce, D. Arik, Z. Kilickap, S. Aksoy, S. Erman, M. Hayran, K.M. Unal, S. Alp, A. Dizdar, O. 1612P Immunogenicity of two doses of inactive COVID-19 vaccine and third booster dose mRNA vaccine in patients with cancer receiving active systemic therapy |
| title | 1612P Immunogenicity of two doses of inactive COVID-19 vaccine and third booster dose mRNA vaccine in patients with cancer receiving active systemic therapy |
| title_full | 1612P Immunogenicity of two doses of inactive COVID-19 vaccine and third booster dose mRNA vaccine in patients with cancer receiving active systemic therapy |
| title_fullStr | 1612P Immunogenicity of two doses of inactive COVID-19 vaccine and third booster dose mRNA vaccine in patients with cancer receiving active systemic therapy |
| title_full_unstemmed | 1612P Immunogenicity of two doses of inactive COVID-19 vaccine and third booster dose mRNA vaccine in patients with cancer receiving active systemic therapy |
| title_short | 1612P Immunogenicity of two doses of inactive COVID-19 vaccine and third booster dose mRNA vaccine in patients with cancer receiving active systemic therapy |
| title_sort | 1612p immunogenicity of two doses of inactive covid-19 vaccine and third booster dose mrna vaccine in patients with cancer receiving active systemic therapy |
| topic | Article |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9472463/ http://dx.doi.org/10.1016/j.annonc.2022.07.1705 |
| work_keys_str_mv | AT guvendcc 1612pimmunogenicityoftwodosesofinactivecovid19vaccineandthirdboosterdosemrnavaccineinpatientswithcancerreceivingactivesystemictherapy AT gulbahceincesufg 1612pimmunogenicityoftwodosesofinactivecovid19vaccineandthirdboosterdosemrnavaccineinpatientswithcancerreceivingactivesystemictherapy AT yildirimhc 1612pimmunogenicityoftwodosesofinactivecovid19vaccineandthirdboosterdosemrnavaccineinpatientswithcancerreceivingactivesystemictherapy AT erule 1612pimmunogenicityoftwodosesofinactivecovid19vaccineandthirdboosterdosemrnavaccineinpatientswithcancerreceivingactivesystemictherapy AT chalabiyeve 1612pimmunogenicityoftwodosesofinactivecovid19vaccineandthirdboosterdosemrnavaccineinpatientswithcancerreceivingactivesystemictherapy AT aktasby 1612pimmunogenicityoftwodosesofinactivecovid19vaccineandthirdboosterdosemrnavaccineinpatientswithcancerreceivingactivesystemictherapy AT yuced 1612pimmunogenicityoftwodosesofinactivecovid19vaccineandthirdboosterdosemrnavaccineinpatientswithcancerreceivingactivesystemictherapy AT arikz 1612pimmunogenicityoftwodosesofinactivecovid19vaccineandthirdboosterdosemrnavaccineinpatientswithcancerreceivingactivesystemictherapy AT kilickaps 1612pimmunogenicityoftwodosesofinactivecovid19vaccineandthirdboosterdosemrnavaccineinpatientswithcancerreceivingactivesystemictherapy AT aksoys 1612pimmunogenicityoftwodosesofinactivecovid19vaccineandthirdboosterdosemrnavaccineinpatientswithcancerreceivingactivesystemictherapy AT ermanm 1612pimmunogenicityoftwodosesofinactivecovid19vaccineandthirdboosterdosemrnavaccineinpatientswithcancerreceivingactivesystemictherapy AT hayrankm 1612pimmunogenicityoftwodosesofinactivecovid19vaccineandthirdboosterdosemrnavaccineinpatientswithcancerreceivingactivesystemictherapy AT unals 1612pimmunogenicityoftwodosesofinactivecovid19vaccineandthirdboosterdosemrnavaccineinpatientswithcancerreceivingactivesystemictherapy AT alpa 1612pimmunogenicityoftwodosesofinactivecovid19vaccineandthirdboosterdosemrnavaccineinpatientswithcancerreceivingactivesystemictherapy AT dizdaro 1612pimmunogenicityoftwodosesofinactivecovid19vaccineandthirdboosterdosemrnavaccineinpatientswithcancerreceivingactivesystemictherapy |